Last updated: May 31, 2026
ELEPSIA XR supplier landscape: Who manufactures, supplies, and sources active ingredients and finished dosage for this gabapentin ER product?
ELEPSIA XR is an extended-release (ER) formulation of gabapentin marketed in multiple countries. A supplier map depends on the specific country market, strength, and market authorization holder (MAH), because manufacturing and packaging are often subcontracted by the MAH and may differ by region. No source set was provided identifying ELEPSIA XR’s authorized MAH, strength-specific labels, or the FDA/EMA/local dossier owner, so a complete and accurate supplier list cannot be produced.
Who are the contract manufacturers and packagers for ELEPSIA XR gabapentin ER in each country?
Featured snippet answer: A defensible list requires the market-specific dossier (MAH) and label package composition. Without the MAH and territory, the set of contract manufacturers and packagers cannot be identified from the record.
Which types of suppliers typically support gabapentin ER (extended-release) products?
- API producers for gabapentin (supply of bulk active)
- Finished dosage manufacturers for ER matrix or coating systems
- Film coating or pressing suppliers (depending on the release technology)
- Packaging and labeling contractors (blister, HDPE bottles, cartons)
- Quality control laboratories (release testing, stability, dissolution profiling)
What raw materials suppliers support gabapentin ER for ELEPSIA XR (API and excipients)?
Featured snippet answer: A defensible supplier list requires the excipient list and the manufacturing site named on regulatory submissions or product labeling for the specific jurisdiction.
Key supply categories that must be traced for ER gabapentin
- Gabapentin API (starting material and route suppliers)
- ER excipient system (matrix/former, binder, disintegrant, lubricant)
- Film coat or controlled-release polymers (if used)
- Compressed tablet consumables (if tablet-based)
- Printing inks and packaging films for traceability
How does ELEPSIA XR’s supply chain compare with other gabapentin ER brands?
Featured snippet answer: Comparison requires knowing the exact branded formulation (tablet/capsule), strengths, and the regulatory listing for each country, then mapping the manufacturing sites and MAHs.
What typically varies across gabapentin ER products
- Release mechanism (matrix vs coated beads, if applicable)
- Excipient selection and tablet hardness/dissolution profile
- Site-specific GMP release responsibility
- Packaging format and labeling artwork supplier
What does the Orange Book or local equivalent list for ELEPSIA XR suppliers?
Featured snippet answer: In the US, the Orange Book lists applicant/holder and patent ties, but it does not directly enumerate contract manufacturers. Mapping suppliers requires cross-referencing labeler, NDC, and facility names, which are not provided.
What to extract from regulatory databases to build a supplier list
- MAH and applicant name
- Labeled manufacturer(s) and packager(s)
- Strength and dosage form linked to NDCs
- Submission history that points to manufacturing sites
Which companies supply ELEPSIA XR generics and authorized brands (licensing and toll manufacturing)?
Featured snippet answer: A supplier and licensing map requires the MAH and any licensing agreements tied to the jurisdiction, which are not provided.
Typical structures for gabapentin ER branded supply
- MAH contracts a toll manufacturer and contract packager
- Brand holder licenses formulation and manufacturing rights
- Distributor supplies via appointed wholesalers but does not own manufacturing
What is the regulatory status of ELEPSIA XR by country, and how does that affect supplier eligibility?
Featured snippet answer: Supplier eligibility changes with local GMP rules, site registrations, and dossier ownership. A jurisdiction is required to identify the correct regulator and the correct submissions.
Regulatory implications for supplier mapping
- EU: manufacturing authorization and QP release tied to named sites
- UK: MHRA and product license details
- Other markets: local MAH and site licensing controls
Key Takeaways
- A complete, accurate ELEPSIA XR supplier list cannot be constructed without the market-specific MAH/labeler and jurisdiction-linked regulatory data.
- Supplier mapping for gabapentin ER requires triangulating MAH/labeler, NDC or national listing, manufacturing site(s), and excipient/API dossier ownership.
- Any supplier list produced without those identifiers risks naming the wrong site, wrong packager, or wrong territory.
FAQs
- How can I identify the contract manufacturer for ELEPSIA XR from public labeling?
- Which regulatory filings reveal the API and excipient supply chain for gabapentin ER?
- Do ELEPSIA XR suppliers differ by country or strength?
- What documentation is needed to link an ELEPSIA XR NDC to the manufacturing site?
- How do contract packagers appear in the product’s regulatory and packaging records?
References
No citations were provided in the prompt, so no source-backed reference list can be generated.
